Relationship between obesity, gut microbiome and hepatocellular carcinoma development

Digestive Diseases

Volumn 33, Issue 3, 2015, Pages 346-350

  Hara, Eiji ^a  

^a CANCER INSTITUTE   (Japan)

Author keywords

Cellular senescence; Deoxycholic acid; Gut microbiota; Liver cancer; Obesity

Indexed keywords

BILE ACID; DEOXYCHOLIC ACID;

CELL AGING; CONFERENCE PAPER; DISEASE ASSOCIATION; DNA DAMAGE; ENTEROHEPATIC CIRCULATION; HUMAN; INTESTINE FLORA; LIVER CANCER; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; METABOLITE; NONALCOHOLIC FATTY LIVER; NONHUMAN; OBESITY; PHENOTYPE; PRIORITY JOURNAL; SENESCENCE ASSOCIATED SECRETORY PHENOTYPE; STELLATE CELL; ANIMAL; CARCINOGENESIS; LIVER TUMOR; METABOLISM; PATHOLOGY; PHYSIOLOGY; SECRETION (PROCESS);

ANIMALS; CARCINOGENESIS; CARCINOMA, HEPATOCELLULAR; CELL AGING; DEOXYCHOLIC ACID; GASTROINTESTINAL MICROBIOME; HEPATIC STELLATE CELLS; HUMANS; LIVER NEOPLASMS; NON-ALCOHOLIC FATTY LIVER DISEASE; OBESITY;

EID: 84930589406     PISSN: 02572753     EISSN: 14219875     Source Type: Journal    
DOI: 10.1159/000371679     Document Type: Conference Paper

References (54)

1. Khandekar MJ, Cohen P, Spiegelman BM: Molecular mechanisms of cancer development in obesity. Nat Rev Cancer 2011; 11: 886-895.
2. Calle EE, Kaaks R: Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms. Nat Rev Cancer 2004; 4: 579-591.
3. Sun B, Karin M: Obesity, inflammation, and liver cancer. J Hepatol 2012; 56: 704-713.
4. d'Adda di Fagagna F: Living on a break: cellular senescence as a DNA-damage response. Nat Rev Cancer 2008; 8: 512-522.
5. Kuilman T, Michaloglou C, Mooi WJ, Peeper DS: The essence of senescence. Genes Dev 2010; 24: 2463-2479.
6. Ohtani N, Hara E: Cellular senescence: roles and mechanisms of cellular senescence in regulation of tissue homeostasis. Cancer Sci 2013; 104: 525-530.
7. Campisi J: Senescent cells, tumor suppression, and organismal aging: good citizens, bad neighbors. Cell 2005; 120: 513-522.
8. Collado M, Serrano M: Senescence in tumours: evidence from mice and humans. Nat Rev Cancer 2010; 10: 51-57.
9. Adams PD: Healing and hurting: molecular mechanisms, functions, and pathologies of cellular senescence. Mol Cell 2009; 36: 2-14.
10. Perez-Mancera PA, Young ARJ, Narita M: Inside and out: the activities of senescence in cancer. Nat Rev Cancer 2014; 14: 547-558.
11. Coppé JP, Patil CK, Rodier F, Sun Y, Muñoz DP, Goldstein J, et al: Senescence-associated secretory phenotypes reveal cell-nonautonomous functions of oncogenic RAS and the p53 tumor suppressor. PLoS Biol 2008; 6: 2853-2868.
12. Rodier F, Campisi J: Four faces of cellular senescence. J Cell Biol 2011; 192: 547-556.
13. Kuilman T, Peeper DS: Senescence-messaging secretome: SMS-ing cellular stress. Nat Rev Cancer 2009; 9: 81-94.
14. Acosta JC, et al: Chemokine signaling via the CXCR2 receptor reinforces senescence. Cell 2008; 133: 1006-1018.
15. Kuilman T, et al: Oncogene-induced senescence relayed by an interleukin-dependent inflammatory network. Cell 2008; 133: 1019-1031.
16. Ventura A, et al: Restoration of p53 function leads to tumour regression in vivo. Nature 2007; 445: 661-665.
17. Xu W, et al: Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas. Nature 2007; 445: 656-660.
18. Kang TW, et al: Senescence surveillance of premalignant hepatocytes limits liver cancer development. Nature 2011; 479: 547-551.
19. Park EJ, Lee JH, Yu GY, He G, Ali SR, Holzer RG, et al: Dietary and genetic obesity promote liver inflammation and tumorigenesis by enhancing IL-6 and TNF expression. Cell 2010; 140: 197-208.
20. Serrano M, Lee H, Chin L, Cordon-Cardo C, Beach D, DePinho RA: Role of the INK4a locus in tumor suppression and cell mortality. Cell 1996; 85: 27-37.
21. Ohtani N, Imamura Y, Yamakoshi K, Hirota F, Nakayama R, Kubo Y, et al: Visualizing the dynamics of p21 Waf1/Cip1 cyclin-dependent kinase inhibitor expression in living animals. Proc Natl Acad Sci USA 2007; 104: 15034-15039.
22. Yoshimoto S, Loo TM, Atarashi K, Kanda H, Sato S, Oyadomari S, et al: Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome. Nature 2013; 499: 97-101.
23. Dimri GP, Lee X, Basile G, Acosta M, Scott G, Roskelley C, et al: A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc Natl Acad Sci USA 1995; 92: 9363-9367.
24. Narita M, N?nez S, Heard E, Narita M, Lin AW, Hearn SA, et al: Rb-mediated heterochromatin formation and silencing of E2F target genes during cellular senescence. Cell 2003; 113: 703-716.
25. Lee BY, Han JA, Im JS, Morrone A, Johung K, Goodwin EC, et al: Senescence-associated -galactosidase is lysosomal -galactosidase. Aging Cell 2006; 5: 187-195.
26. Di Micco R, Sulli G, Dobreva M, Liontos M, Botrugno OA, Gargiulo G, et al: Interplay between oncogene-induced DNA damage response and heterochromatin in senescence and cancer. Nat Cell Biol 2011; 13: 292-302.
27. Kosar M, Bartkova J, Hubackova S, Hodny Z, Lukas J, Bartek J: Senescence-associated heterochromatin foci are dispensable for cellular senescence, occur in a cell type-and insult-dependent manner and follow expression of p16(ink4a). Cell Cycle 2011; 10: 457-468.
28. Kennedy AL, McBryan T, Enders GH, Johnson FB, Zhang R, Adams PD: Senescent mouse cells fail to overtly regulate the HIRA histone chaperone and do not form robust senescence associated heterochromatin foci. Cell Div 2010; 5: 16.
29. Imai Y, Takahashi A, Hanyu A, Hori S, Naka K, Hirao A, et al: Crosstalk between the Rb pathway and AKT signaling forms aquiescence-senescence switch. Cell Rep 2014; 7: 194-207.
30. Orjalo AV, Bhaumik D, Gengler BK, Scott GK, Campisi J. Cell surface-bound IL-1alpha is an upstream regulator of the senescence-associated IL-6/IL-8 cytokine network. Proc Natl Acad Sci USA 2009; 106: 17031-17036.
31. Acosta JC, Banito A, Wuestefeld T, Georgilis A, Janich P, Morton JP, et al: A complex secretory program orchestrated by the inflammasome controls paracrine senescence. Nat Cell Biol 2013; 15: 978-990.
32. Yang L, Jung Y, Omenetti A, Witek RP, Choi S, Vandongen HM, et al: Fate-mapping evidence that hepatic stellate cells are epithelial progenitors in adult mouse livers. Stem Cells 2008; 26: 2104-2113.
33. Sato Y, Murase K, Kato J, Kobune M, Sato T, Kawano Y, et al: Resolution of liver cirrhosis using vitamin A-coupled liposomes to deliver siRNA against a collagen-specific chaperone. Nat Biotechnol 2008; 26: 431-442.
34. Cougnoux A, Dalmasso G, Martinez R, Buc E, Delmas J, Gibold L, et al: Bacterial genotoxin colibactin promotes colon tumour growth by inducing a senescence-associated secretory phenotype. Gut 2014; 63: 1932-1942.
35. Lujambio A, Akkari L, Simon J, Grace D, Tschharganeh DF, Bolden JE, et al: Non-cell autonomous tumor suppression by p53. Cell 2013; 153: 449-460.
36. Pribluda A, Elyada E, Wiener Z, Hamza H, Goldstein RE, Biton M, et al: A senescence-inflammatory switch from cancer-inhibitory to cancer-promoting mechanism. Cancer Cell 2013; 24: 242-256.
37. Ley RE, Turnbaugh PJ, Klein S, Gordon JI: Microbial ecology: human gut microbes associated with obesity. Nature 2006; 444: 1022-1023.
38. Turnbaugh PJ, Ley RE, Mahowald MA, Magrini V, Mardis ER, Gordon JI: An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 2006; 444: 1027-1031.
39. Dapito DH, Mencin A, Gwak GY, Pradere JP, Jang MK, Mederacke I, et al: Promotion of hepatocellular carcinoma by the intestinal microbiota and TLR4. Cancer Cell 2012; 21: 504-516.
40. Payne CM, Weber C, Crowley-Skillicorn C, Dvorak K, Bernstein H, Bernstein C, et al: Deoxycholate induces mitochondrial oxidative stress and activates NF-kappaB through multiple mechanisms in HCT-116 colon epithelial cells. Carcinogenesis 2007; 28: 215-222.
41. Kitazawa S, Denda A, Tsutsumi M, Tsujiuchi T, Hasegawa K, Tamura K, et al: Enhanced preneoplastic liver lesion development under selection pressure' conditions after administration of deoxycholic or lithocholic acid in the initiation phase in rats. Carcinogenesis 1990; 11: 1323-1328.
42. Ridlon JM, Hylemon PB: Identification and characterization of two bile acid coenzyme A transferases from Clostridium scindens, a bile acid 7-dehydroxylating intestinal bacterium. J Lipid Res 2012; 53: 66-76.
43. Calle EE, Rodriguez C, Walker-Thunmond K, Thun MJ: Overweight, obesity, and mortality from cancer in a prospectively studies cohort of U. S. adults. N Engl J Med 2003; 348: 1625-1638.
44. Samanic C, Gridley G, Chow WH, Lubin J, Hoover RN, Fraumeni JF Jr: Obesity and cancer risk among white and black United States veterans. Cancer Causes Control 2004; 15: 35-43.
45. Møller H, Mellemgaard A, Lindvig K, Olsen JH: Obesity and cancer risk: A Danish recordlinkage study. Eur J Cancer 1994; 30A:344-350.
46. Wolk A, Gridley G, Svensson M, Nyrén O, McLaughlin JK, Fraumeni JF, et al: A prospective study of obesity and cancer risk (Sweden). Cancer Causes Control 2001; 12: 13-21.
47. Chen CL, Yang HI, Yang WS, Liu CJ, Chen PJ, You SL, et al: Metabolic factors and risk of hepatocellular carcinoma by chronic hepatitis B/C infection: A follow-up study in Taiwan. Gastroenterology 2008; 135: 111-121.
48. Haslam DW, James WPT: Obesity. Lancet 2005; 366: 1197-1209.
49. Torres DM, Harrison SA: Nonalcholic steatohepatitis and noncirrhotic hepatocellular carcinoma: fertile soil. Semin Liver Dis 2012; 32: 30-38.
50. Rafter JJ, Child P, Anderson AM, Alder R, Eng V, Bruce WR: Cellular toxicity of fecal water depends on diet. Am J Clin Nutr 1987; 45: 559-563.
51. David LA, Maurice CF, Carmody RN, Gootenberg DB, Button JE, Wolfe BE, et al: Diet rapidly and reproducibly alters the human gut microbiome. Nature 2014; 505: 559-563.
52. Schnabl B, Purbeck CA, Choi YH, Hagedorn CH, Brenner D: Replicative senescence of activated human hepatic stellate cells is accompanied by a pronounced inflammatory but less fibrogenic phenotype. Hepatology 2003; 37: 653-664.
53. Newell P, Toffanin S, Villanueva A, Chiang DY, Minguez B, Cabellos L, et al: Ras pathway activation in hepatocellular carcinoma and anti-tumoral effect of combined sorafenib and rapamycin in vivo. J Hepatol 2009; 51: 725-733.
54. McGarr SE, Ridlon JM, Hylemon PB: Diet, anaerobic bacterial metabolism, and colon cancer: A review of the literature. J Clin Gastroenterol 2005; 39: 98-109.